Startups

Here is an eye-opening number. In 2020, more than $36 billion dollars were invested in biotech and science related startups / enterprises. Some of the other financial numbers related to startups are even more compelling, reflecting the importance of this form of business opportunity. While Europe doubled its investments in these ventures, China has been like an unrestrained horse, providing not just the initial investment but also multiple rounds of funding.

Archerchem has recognized the significance of these startups and therefore has reserved a portion of its capital for early stage ventures, mentorship and strategic collaboration in the healthcare sphere.